| 5.47 -0.11 (-1.97%) | 04-30 12:56 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 6.9 | 1-year : | 7.46 |
| Resists | First : | 5.91 | Second : | 6.38 |
| Pivot price | 5.51 |
|||
| Supports | First : | 5.13 | Second : | 4.27 |
| MAs | MA(5) : | 5.55 |
MA(20) : | 5.51 |
| MA(100) : | 6.52 |
MA(250) : | 6.96  |
|
| MACD | MACD : | -0.1 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 66.6 |
D(3) : | 70.1 |
| RSI | RSI(14): 43.1 |
|||
| 52-week | High : | 9.93 | Low : | 4.5 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ AIRS ] has closed above bottom band by 38.7%. Bollinger Bands are 56.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 5.75 - 5.78 | 5.78 - 5.8 |
| Low: | 5.27 - 5.31 | 5.31 - 5.34 |
| Close: | 5.51 - 5.58 | 5.58 - 5.63 |
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. It offers custom body contouring using its AirSculpt procedure that removes unwanted fat in a minimally invasive procedure. The company provides fat removal procedures across treatment areas; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. Its body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. As of March 10, 2022, it operated 19 centers across 15 states. AirSculpt Technologies, Inc. was founded in 2012 and is headquartered in Miami Beach, Florida.
Mon, 29 Apr 2024
AirSculpt® Relocates and Expands to New Location to Meet Market Demand - InvestorsObserver
Thu, 04 Apr 2024
There's Been No Shortage Of Growth Recently For AirSculpt Technologies' (NASDAQ:AIRS) Returns On Capital - Simply Wall St
Mon, 01 Apr 2024
AirSculpt Technologies, Inc. (NASDAQ:AIRS) Short Interest Down 6.4% in March - MarketBeat
Mon, 11 Mar 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of AirSculpt Technologies ... - PR Newswire
Fri, 01 Mar 2024
AirSculpt Technologies, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now - Yahoo Finance
Tue, 27 Feb 2024
AirSculpt Technologies Inc (AIRS) Reports Strong Revenue and EBITDA Growth in Q4 and Full Year 2023 - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 58 (M) |
| Shares Float | 9 (M) |
| Held by Insiders | 26.2 (%) |
| Held by Institutions | 75.7 (%) |
| Shares Short | 2,160 (K) |
| Shares Short P.Month | 2,360 (K) |
| EPS | -0.08 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.46 |
| Profit Margin | -2.3 % |
| Operating Margin | 2.9 % |
| Return on Assets (ttm) | 2.8 % |
| Return on Equity (ttm) | -5.8 % |
| Qtrly Rev. Growth | 17 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 3.4 |
| EBITDA (p.s.) | 0.33 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 24 (M) |
| Levered Free Cash Flow | 19 (M) |
| PE Ratio | -68.13 |
| PEG Ratio | 0.4 |
| Price to Book value | 3.73 |
| Price to Sales | 1.6 |
| Price to Cash Flow | 13.08 |
| Dividend | 0.4 |
| Forward Dividend | 0 |
| Dividend Yield | 7.5% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|